The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
October 29th 2024
The AI-enabled AutoChamber software also garnered the FDA’s breakthrough device designation for opportunistic detection of enlarged heart chambers on non-contrast CT scans.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Report from SNM: Images of the Year cover molecular imaging from head to toe
June 17th 2008Dr. Henry J. Wagner Jr. has selected two images, a PET/CT scan showing the early metastatic spread of tumor in a patient’s ear and a SPECT/MRI study of osteomyelitis in another patient’s foot, to exemplify the diagnostic capabilities of nuclear medicine as the 2008 Society of Nuclear Medicine Image of the Year.
Report from SNM: PET/CT restaging alters management for one-third of breast cancer cases
June 16th 2008FDG-PET/CT is gaining attention for its role in staging and restaging breast cancer. A trial from the Technical University of Munich, presented Sunday at the 2008 Society of Nuclear Medicine meeting in New Orleans, found that PET/CT detected local or distant recurrence in 67% of breast cancer patients and changed the management plan in 33% of the cases.
Fear of nuclear terrorism lurks behind molybdenum supply debate
June 3rd 2008The crash of the radioisotope supply last winter gets a close look in this month's cover story. It details the politics and policy issues that closed down the Chalk River reactor in Ontario for nearly a month, leaving North American nuclear medicine physicians without a reliable supply of technetium-99.
Isotope supply crash drives push for new moly sources
June 3rd 2008Knowledgeable Canadians considered the molybdenum-99 crisis of 2007 a national disgrace. A squabble between the Canadian Nuclear Safety Commission and Atomic Energy Canada, the federal corporation that owns and operates nuclear research facilities at Chalk River, ON, forced the National Research Universal reactor there to shut down. That action triggered a crisis that cut off production of molybdenum-99, the isotope that produces technetium-99m for thousands of health facilities across Canada and the U.S.
Canadian agency pulls plug on molybdenum reactors
May 19th 2008Atomic Energy Canada has halted development work on twin reactors at Chalk River, ON. They were the planned successors for an aging research nuclear reactor that is the source of molybdenum-99 isotope used in 19 million nuclear medicine imaging procedures annually.
Ground-glass nodules merit scrutiny for differential diagnosis
May 16th 2008Persistent ground-glass nodules in the lungs are worth a closer look, as they are highly associated with malignancy. Dr. Anne Leung offered an overview of how these lesions present on CT imaging at the 2008 Stanford International Symposium on Multidetector-Row CT in Las Vegas.
Flat polyps raise questions in colon cancer screening
May 1st 2008Truly flat or depressed colorectal polyps pose a diagnostic dilemma and are always worth a closer look. A study in the Journal of the American Medical Association may have overstated the case, however, by concluding that these polyps were quite common and carried an increased cancer risk, according to CT colonography experts.
CT colonography experts plan for growing demand
May 1st 2008Academic radiologists who helped invent CT colonography are urging their community-based colleagues to gear up for a possible jump in public demand for CTC following the American Cancer Society's decision in March to add the procedure to its list of preferred colon cancer screening options.
Nuclear studies show benefits of progenitor cell therapy
April 11th 2008German researchers have demonstrated the value of PET and SPECT imaging for monitoring the ability of circulating progenitor cells injected in the coronary arteries to preserve the integrity of myocardial tissue following recanalization.
DI challenges readers to swallow story that features pointed findings
April 1st 2008We hope one of the things that distinguishes us from other medical imaging media is our sense of fun. The practice and science of radiology can be scintillating reading (especially when it relates to nuclear medicine), but it can require intense mental concentration as well.
CT colonography experts assess new screening guidelines
March 17th 2008The American Cancer Society’s green light for CT colonography as a preferred modality for colon cancer screening is a major victory for proponents, but they are not resting on their laurels. Imaging and gastroenterology experts must gear up for widespread dissemination of the procedure, according to Drs. Judy Yee and Beth McFarland.